These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 17251916)

  • 1. Immunostimulatory monoclonal antibodies for cancer therapy.
    Melero I; Hervas-Stubbs S; Glennie M; Pardoll DM; Chen L
    Nat Rev Cancer; 2007 Feb; 7(2):95-106. PubMed ID: 17251916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of immunostimulatory monoclonal antibodies.
    Gray JC; Johnson PW; Glennie MJ
    Clin Sci (Lond); 2006 Aug; 111(2):93-106. PubMed ID: 16831129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using monoclonal antibodies to stimulate antitumor cellular immunity.
    Durrant LG; Pudney VA; Spendlove I
    Expert Rev Vaccines; 2011 Jul; 10(7):1093-106. PubMed ID: 21806402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible applications of antibodies or their genes in cancer therapy.
    Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
    Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination.
    Melero I; Grimaldi AM; Perez-Gracia JL; Ascierto PA
    Clin Cancer Res; 2013 Mar; 19(5):997-1008. PubMed ID: 23460531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in clinical hematology and oncology.
    Nagorsen D; Thiel E
    Curr Opin Investig Drugs; 2007 Dec; 8(12):996-1001. PubMed ID: 18058570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.
    Roses RE; Xu M; Koski GK; Czerniecki BJ
    Oncogene; 2008 Jan; 27(2):200-7. PubMed ID: 18176601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing antibodies for oncology.
    Tanner JE
    Cancer Metastasis Rev; 2005 Dec; 24(4):585-98. PubMed ID: 16408163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4: negative regulator of the immune response and a target for cancer therapy.
    Keilholz U
    J Immunother; 2008 Jun; 31(5):431-9. PubMed ID: 18463542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies in therapy of solid tumors.
    Heimann DM; Weiner LM
    Surg Oncol Clin N Am; 2007 Oct; 16(4):775-92, viii. PubMed ID: 18022544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune modulation in melanoma and advanced cancer therapy: anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibodies.
    Esper P
    Clin J Oncol Nurs; 2009 Oct; 13(5):547-54. PubMed ID: 19793711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.
    Frederick PJ; Straughn JM; Alvarez RD; Buchsbaum DJ
    Gynecol Oncol; 2009 Jun; 113(3):384-90. PubMed ID: 19232697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody therapy for prostate cancer.
    Jakobovits A
    Handb Exp Pharmacol; 2008; (181):237-56. PubMed ID: 18071949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune response.
    Baghdadi M; Takeuchi S; Wada H; Seino K
    MAbs; 2014; 6(5):1124-32. PubMed ID: 25517298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-targeted vaccines.
    Keler T; He L; Ramakrishna V; Champion B
    Oncogene; 2007 May; 26(25):3758-67. PubMed ID: 17530028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.